Greenwood Gearhart’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76M Buy
479,226
+16,722
+4% +$2.49M 3.54% 7
2026
Q1
$67.8M Buy
462,504
+14,068
+3% +$2.17M 3.67% 8
2025
Q4
$69.4M Buy
448,436
+9,435
+2% +$1.41M 3.82% 7
2025
Q3
$61.1M Buy
439,001
+14,706
+3% +$1.99M 3.52% 7
2025
Q2
$57.2M Buy
424,295
+95,589
+29% +$12.9M 3.57% 7
2025
Q1
$48M Buy
328,706
+2,834
+0.9% +$412K 3.32% 9
2024
Q4
$44.8M Buy
325,872
+92,996
+40% +$13.6M 3.09% 8
2024
Q3
$35.9M Buy
232,876
+19,720
+9% +$2.99M 2.98% 6
2024
Q2
$31.1M Buy
213,156
+1,767
+0.8% +$253K 2.93% 7
2024
Q1
$31.2M Buy
211,389
+3,638
+2% +$522K 3.05% 8
2023
Q4
$28.3M Buy
207,751
+115,270
+125% +$15M 3.02% 10
2023
Q3
$11.9M Buy
92,481
+1,909
+2% +$253K 1.41% 32
2023
Q2
$12M Buy
+90,572
New +$11.9M 1.4% 34

Other funds holding XLV

Greenwood Gearhart's XLV Position: Q2 2026 in Review

Greenwood Gearhart increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 3.6% in Q2 2026, buying an estimated $2.49M and bringing the position to 479,226 shares worth $76M. The position accounts for 3.54% of the portfolio, ranked #7.

Greenwood Gearhart first reported a position in XLV in Q2 2023 and has held it in 13 quarters since. 882 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

  • Greenwood Gearhart held 479,226 shares of State Street Health Care Select Sector SPDR ETF worth $76M as of Q2 2026.
  • Greenwood Gearhart bought 16,722 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $2.49M.
  • State Street Health Care Select Sector SPDR ETF made up 3.54% of Greenwood Gearhart's portfolio in Q2 2026, its #7 holding.
  • Greenwood Gearhart first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2023 and has held it in 13 quarters since.
  • 882 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Greenwood Gearhart's 13F filing for Q2 2026, filed 24 Jul 2026.